Alec W Petersen1, Avantika S Shah1, Sandra F Simmons1, Matthew S Shotwell2, J Mary Lou Jacobsen3, Amy P Myers4, Amanda S Mixon5, Susan P Bell1, Sunil Kripalani6, John F Schnelle1, Eduard E Vasilevskis7. 1. Center for Quality Aging, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Department of Biostatistics, Vanderbilt University, Nashville, TN, USA. 3. Center for Quality Aging, Vanderbilt University Medical Center, Nashville, TN. 4. Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN, USA. 5. Geriatric Research Education and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, TN, USA. 6. Section of Hospital Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. 7. Vanderbilt Center for Health Services Research, Center for Quality Aging, Division of General Internal Medicine and Public Health, Geriatric Research Education and Clinical Center, VA Tennessee Valley, 2525 West End Ave, Suite 450, Nashville, TN 37203, USA.
Abstract
BACKGROUND: Polypharmacy is common in hospitalized older adults. Deprescribing interventions are not well described in the acute-care setting. The objective of this study was to describe a hospital-based, patient-centered deprescribing protocol (Shed-MEDS) and report pilot results. METHODS: This was a pilot study set in one academic medical center in the United States. Participants consisted of a convenience sample of 40 Medicare-eligible, hospitalized patients with at least five prescribed medications. A deprescribing protocol (Shed-MEDS) was implemented among 20 intervention and 20 usual care control patients during their hospital stay. The primary outcome was the total number of medications deprescribed from hospital enrollment. Deprescribed was defined as medication termination or dose reduction. Enrollment medications reflected all prehospital medications and active in-hospital medications. Baseline characteristics and outcomes were compared between the intervention and usual care groups using simple logistic or linear regression for categorical and continuous measures, respectively. RESULTS: There was no significant difference between groups in mean age, sex or Charlson comorbidity index. The intervention and control groups had a comparable number of medications at enrollment, 25.2 (±6.3) and 23.4 (±3.8), respectively. The number of prehospital medications in each group was 13.3 (±4.6) and 15.3 (±4.6), respectively. The Shed-MEDS protocol compared with usual care significantly increased the mean number of deprescribed medications at hospital discharge and reduced the total medication burden by 11.6 versus 9.1 (p = 0.032) medications. The deprescribing intervention was associated with a difference of 4.6 [95% confidence interval (CI) 2.5-6.7, p < 0.001] in deprescribed medications and a 0.5 point reduction (95% CI -0.01 to 1.1) in the drug burden index. CONCLUSIONS: A hospital-based, patient-centered deprescribing intervention is feasible and may reduce the medication burden in older adults.
BACKGROUND: Polypharmacy is common in hospitalized older adults. Deprescribing interventions are not well described in the acute-care setting. The objective of this study was to describe a hospital-based, patient-centered deprescribing protocol (Shed-MEDS) and report pilot results. METHODS: This was a pilot study set in one academic medical center in the United States. Participants consisted of a convenience sample of 40 Medicare-eligible, hospitalized patients with at least five prescribed medications. A deprescribing protocol (Shed-MEDS) was implemented among 20 intervention and 20 usual care control patients during their hospital stay. The primary outcome was the total number of medications deprescribed from hospital enrollment. Deprescribed was defined as medication termination or dose reduction. Enrollment medications reflected all prehospital medications and active in-hospital medications. Baseline characteristics and outcomes were compared between the intervention and usual care groups using simple logistic or linear regression for categorical and continuous measures, respectively. RESULTS: There was no significant difference between groups in mean age, sex or Charlson comorbidity index. The intervention and control groups had a comparable number of medications at enrollment, 25.2 (±6.3) and 23.4 (±3.8), respectively. The number of prehospital medications in each group was 13.3 (±4.6) and 15.3 (±4.6), respectively. The Shed-MEDS protocol compared with usual care significantly increased the mean number of deprescribed medications at hospital discharge and reduced the total medication burden by 11.6 versus 9.1 (p = 0.032) medications. The deprescribing intervention was associated with a difference of 4.6 [95% confidence interval (CI) 2.5-6.7, p < 0.001] in deprescribed medications and a 0.5 point reduction (95% CI -0.01 to 1.1) in the drug burden index. CONCLUSIONS: A hospital-based, patient-centered deprescribing intervention is feasible and may reduce the medication burden in older adults.
Entities:
Keywords:
deprescribing; geriatric syndromes; hospital; polypharmacy; postacute care
Authors: Emily Reeve; Michael D Wiese; Ivanka Hendrix; Michael S Roberts; Sepehr Shakib Journal: J Am Geriatr Soc Date: 2013-08-26 Impact factor: 5.562
Authors: Alexander Bennett; Danijela Gnjidic; Mark Gillett; Peter Carroll; Slade Matthews; Kristina Johnell; Johan Fastbom; Sarah Hilmer Journal: Drugs Aging Date: 2014-03 Impact factor: 3.923
Authors: Danijela Gnjidic; Sarah N Hilmer; Fiona M Blyth; Vasi Naganathan; Louise Waite; Markus J Seibel; Andrew J McLachlan; Robert G Cumming; David J Handelsman; David G Le Couteur Journal: J Clin Epidemiol Date: 2012-06-27 Impact factor: 6.437
Authors: Susan M Patterson; Cathal A Cadogan; Ngaire Kerse; Chris R Cardwell; Marie C Bradley; Cristin Ryan; Carmel Hughes Journal: Cochrane Database Syst Rev Date: 2014-10-07
Authors: Joanne Reeve; Michelle Maden; Ruaraidh Hill; Amadea Turk; Kamal Mahtani; Geoff Wong; Dan Lasserson; Janet Krska; Dee Mangin; Richard Byng; Emma Wallace; Ed Ranson Journal: Health Technol Assess Date: 2022-07 Impact factor: 4.106
Authors: Amadea Turk; Geoffrey Wong; Kamal R Mahtani; Michelle Maden; Ruaraidh Hill; Ed Ranson; Emma Wallace; Janet Krska; Dee Mangin; Richard Byng; Daniel Lasserson; Joanne Reeve Journal: BMC Med Date: 2022-08-31 Impact factor: 11.150
Authors: Melissa J Lefebvre; Patrick C K Ng; Arlene Desjarlais; Dennis McCann; Blair Waldvogel; Marcello Tonelli; Amit X Garg; Jo-Anne Wilson; Monica Beaulieu; Judith Marin; Cali Orsulak; Anita Lloyd; Caitlin McIntyre; Jordanne Feldberg; Clara Bohm; Marisa Battistella Journal: Can J Kidney Health Dis Date: 2020-10-29